Exchange Announcement • 02 Jun 2026 13:00
Exchange Announcement • 11 May 2026 21:06
Exchange Announcement • 11 May 2026 17:05
Exchange Announcement • 05 May 2026 13:00
Exchange Announcement • 30 Mar 2026 13:00
𝛼SK or SearchENTITY
Fusion Antibodies (FAB LN)
Fusion Antibodies (FAB LN)
13
Analysis
Health Care • United Kingdom
Fusion Antibodies Ltd operates as a bio-technology company. The Company develops antibodies for therapeutic drug and diagnostic applications. Fusion Antibodies also renders antibody class switching, stable cell line development, mammalian transient and bacterial protein expression, custom monoclonal antibody production, and sequencing services.
morex